ATP6L, the C subunit of the V-ATPase V0 domain, is involved in regulating the acidic tumor micro-environment and may promote tumor progression. However, the expression and functional role of ATP6L in tumors have not yet been well explored.
| INTRODUC TI ON
Colorectal carcinoma (CRC) is the third most common cancer worldwide. 1 The incidence and mortality rate of CRC are rapidly increasing, especially in developing countries. 2 According to 2015 cancer statistics, the incidence of CRC will increase by 60% by 2030. 1 Despite the overall increase in the survival of CRC patients due to chemotherapy and targeted therapy over the past two decades, metastasis remains the major obstacle in CRC treatment and prognosis. 2, 3 Paget first proposed the "seed and soil" theory, emphasizing the importance of the tumor microenvironment (TME) with hypoxia, elevated interstitial fluid pressure, low glucose level and acidic extracellular pH. 4, 5 Extensive evidence has shown that the interaction between tumor cells and TME contributes to the malignant progression of tumor cells; therefore, studies on the molecular mechanisms underlying TME may help people to develop more effective treatment modalities. 6 One of the hallmarks of TME is the existence of an unusual acidic microenvironment. Most malignant lesions produce energy by glycolysis at a vastly higher rate than normal tissues even in oxygenated environments; this process is known as the Warburg effect. 7 Coupled with abnormal blood perfusion, the infinite proliferation cycle of cancer cells sharply increases oxygen consumption and leads to the accumulation of lactic acid, the product of glycolysis, thereby creating a high acid load in tumor tissues. 7 Acidic gradients are toxic to normal cells because cellular acidosis is a trigger for apoptosis. 8 In contrast, low extracellular pH confers multiple advantages to the process of tumorigenesis and metastasis by promoting cancer cell proliferation, degrading the extracellular matrix, suppressing the host immune system and promoting angiogenesis. [8] [9] [10] Clinical investigations have shown that acidic environments are associated with increased mutation rate, enhanced metastatic incidence and poor prognosis of patients with malignant tumors. 11, 12 In addition, anticancer agents are usually sensitive to pH alteration.
Acidic environments may reduce the uptake and cytotoxicity of anticancer agents, further aiding tumor chemoresistance. 13 To stay alive, cancer cells must pump excess protons into the extracellular environment and maintain a relatively neutral intracellular pH.
Vacuolar H+-ATPase (V-ATPase) uses the energy produced by ATP hydrolysis to pump protons into the lumina of acidic vacuoles or to the extracellular environment. 14 Accumulating clinical evidence has revealed that V-ATPase is overexpressed in various types of cancers, including melanoma, prostate, breast and pancreatic cancer cells. [15] [16] [17] [18] V-ATPase has been implicated in many aspects of tumor development, particularly in the proliferation, resistance to apoptosis and senescence of cancer stem cells (CSC) and invasion and metastasis. 14 ATP6L, the C subunit of the V-ATPase V0 domain, presents in multiple copies per V-ATPase, making it the most critical subunit of V-ATPase. 19 This subunit is highly hydrophobic and responsible for transmembrane proton transport. 14 ATP6L expression is markedly increased in pancreatic cancer and hepatocellular carcinoma. 15, 20 However, the expression and functional role of ATP6L in other types of cancer is still poorly understood.
In this study, the clinicopathological significance of ATP6L and the correlation between ATP6L expression and EMT immunohisto- None of the patients had received any chemotherapy or radiotherapy before their operation. Data of clinicopathological parameters were obtained from patients' clinical records and pathological reports. All the samples underwent a uniform protocol for fixation/ dissection. All sections were evaluated by two senior pathologists.
| MATERIAL S AND ME THODS

| Clinical samples
The use of the tissue samples in this study was approved by the Institutional Research Committee. 
| Cell culture reagents and animals
| Immunohistochemical staining
Streptavidin-biotin-peroxidase staining was performed as previously described. 21 In a typical procedure, the sections were pretreated with microwaves, blocked and incubated with a series of antibodies overnight at 4°C. Then, they were immunostained with HRP-conjugated antibody and signals were revealed, with 3,3-diaminobenzidine buffer used as substrate. In place of primary antibodies for the negative control, PBS was used.
The expression of ATP6L, E-cadherin and vimentin was analyzed only histologically in normal and neoplastic epithelial cells and not in stromal tissues. ATP6L staining was considered immunoreactive when brown granules were identified in the cytoplasm. The staining intensity of ATP6L was graded on a scale from 0 to 2 (0 for no staining, 1 for weak immunoreactivity and 2 for strong immunoreactivity). Percentage immunoreactivity was scored on a scale from 0 to 3 (0 for <10% of cells being positive, 1 for <30% of cells being positive, 2 for 30%-60% of cells being positive and 3 for >50% of cells being positive). We multiplied the two scores to obtain a composite ATP6L expression score. ATP6L expression was classified as negative (−) (score = 0), weakly positive (+) score = (1, 2, or 3) or strongly positive (++) (score = 4, 5 or 6). E-cadherin expression was considered to be positive if >90% of cancer cells exhibited a staining pattern similar to that in normal epithelial cells. Vimentin expression was classified as positive when >10% tumor cells were stained. 
| Plasmid transfection
| Western blot analysis
Protein (30-50 μg/lane) was separated by 10% SDS-PAGE and transferred to polyvinylidene difluoride membranes. Blots were blocked and incubated with primary antibodies overnight at 4°C, incubated with secondary antibody, and detected with ECL western blot substrate (Millipore) according to the manufacturer's instructions.
| Cell proliferation assay
Cells were separately seeded into 96-well plates at 1 × 10 3 /well and incubated for different periods (1, 2, 3, 4 or 5 days). After 4 hours of incubation at 37°C, MTT (Sigma-Aldrich) solution was added. The purple crystals were dissolved by DMSO. The optical density was determined at 490 nm using a Spectra Max M2 (Molecular Devices).
| Migration/invasion assay
Cell motility was examined in a transwell assay using 24-well plates with uncoated inserts (8-μm pore, BD Biosciences) to examine migration or Matrigel-coated inserts to assess invasiveness. Briefly, 200 μL of cell suspension (5 × 10 5 cells/mL) contained in serum-free medium was added to the upper part, and 300 μL of culture medium supplemented with 20% FBS was added to the lower chamber. After incubation at 37°C with 5% CO 2 for 24 hours, the cells were fixed and stained. The entire membrane was counted by light microscopy in six random fields.
| Immunofluorescence confocal microscopy
Cells were cultured on sterile glass cover slips on the day before staining. Cells were fixed with 4% paraformaldehyde, quenched with 50 mmol/L NH 4 Cl, permeabilized in 0.2% Triton X-100, and blocked in 3% BSA. The slips were incubated with the primary antibodies overnight at 4°C, labeled with the specific secondary antibodies for 1 hour in the dark, mounted, and visualized with a confocal laser scanning microscope (Leica TCS SP5, Leica Microsystems).
| In vivo assay
To generate murine subcutaneous tumors, 20 mice were randomly and evenly divided into two groups and given either 3 × 10 6 control or HCT116 cells overexpressing ATP6L by subcutaneous injection in the right groin. Tumor size was measured every 5 days for 30 days.
Tumor volumes were calculated using the following formula: volume = (length [in millimeters] × width 2 [in square millimeters])/2.
To generate lung metastasis models, the control and HCT116 cells overexpressing ATP6L cells (10 mice/group, 3 × 10 6 /mL; 0.15 mL per mice) were injected into the tail vein. After 3 weeks, the mice were killed, and viscera (lung, liver, kidney and spleen) were harvested.
Tumor samples or harvested viscera tissue were formalin-fixed and paraffin-embedded. The tissues were then subjected to H&E and immunohistochemical staining.
| H&E staining and the evaluation of the nonnecrosis area and microvessel density
H&E staining was performed to examine the necrosis of the tumor mass of xenograft mice. Tissue samples were sectioned (thickness, 4 μm) and deparaffinized in xylene. Tissue sections were stained with H&E, cleared in xylene and mounted on slides using neutral balsam.
The photos were captured using the software Image-Pro Plus (Media Cybernetics). Based on the different color of the necrotic and nonnecrotic areas, the software calculated the level of non-necrosis (as a percentage of the total area relative to the entire histological section).
The results were presented as mean and SD. Microvessel density (MVD) was determined by immunohistochemical staining of CD34.
Ten separate areas with the highest density of discrete microvessels within each section were selected for vessel quantification at ×200 magnification. The results were presented as mean and SD. 
F I G U R E 1 Expression of ATP6L by
| RE SULTS
| Association of ATP6L expression with clinicopathological features of colorectal carcinoma
A total of 167 (86.5%) patients showed positive ATP6L expression, whereas the remaining 26 (13.5%) showed negative ATP6L expression. Tumors were categorized as strong (++), weak (+) or negative (−) for ATP6L expression ( Figure 1A ). The relationship of ATP6L level in CRC with each clinicopathological parameter was analyzed ( Differences in ATP6L expression levels within tumors were found. Tumor cells close to the adjacent interstitial component showed higher ATP6L expression than those at the cancer center ( Figure 1B) .
ATP6L expression was also analyzed in the 20 sets of matched specimens (including primary foci and liver metastatic foci) obtained from each patient. Table 2 and Figure 1C show the upregulated ATP6L expression in liver metastatic foci as compared with that in the primary cancer in each patient. These data indicate that ATP6L is involved in tumor progression in CRC.
| ATP6L expression is concomitant with epithelialmesenchymal transition immunohistochemical features
To assess the relationship between ATP6L and EMT in CRC, we investigated the expression of the EMT-associated markers E-cadherin and vimentin. As shown in Table 3 and Figure 2 , the ATP6L-negative/ weak expression group showed higher E-cadherin expression and lower vimentin expression than the group with ATP6L strong expression. The expression of ATP6L was correlated with the expression of E-cadherin (P = 0.021) and vimentin (P = 0.004) ( Table 3 ). These findings confirm the role of ATP6L in activating the EMT program. 
| ATP6L overexpression induces epithelialmesenchymal transition and changes the morphology of HCT116 and HT29 cells
We established ATP6L-overexpressed and ATP6L knockdown (Figure 3A,B) .
In addition to classical EMT markers, we examined the expression of a set of EMT transcription factors, namely, Snail, Slug and Twist, which can repress E-cadherin expression by binding to the E-boxes of E-cadherin promoter directly. Among them, Snail was upregulated in both HCT116 and HT29 cells that overexpressed ATP6L, whereas the expression levels of Slug showed no significant change ( Figure 3B ).
Twist was upregulated in ATP6L-overexpressed HCT 116 cells, but its expression in ATP6L-overexpressed HT29 cells showed no obvious change ( Figure 3B ). Expression of Snail and Twist was decreased in both the ATP6L knockdown HCT116 and HT29 cells, whereas the expression levels of Slug showed no significant change ( Figure 3B ).
We also observed alterations in cellular morphology and functional phenotypes other than in epithelial and mesenchymal protein expression. A portion of the cytoskeleton was observed by using phalloidin to dye fibrous actin (F-actin). This observation revealed that ATP6L overexpression caused HCT116 and HT29 cells to exhibit a scattered, spindle, mesenchymal-like shape, whereas control cells showed a tightly, uniform, cuboid-like appearance ( Figure 3C ). As we expected, knockdown of ATP6L resulted in restoration of epithelial phenotypes ( Figure 3C ). These findings suggested that cells overexpressing ATP6L are susceptible to mesenchymal differentiation.
| ATP6L expression promotes migration and invasion ability of HCT116 and HT29 cells in vivo
The proliferation rate of cells with either increased or decreased ATP6L expression showed no significant differences from that of control cells when an MTT assay was used ( Figure 4A ) 
| Overexpression of ATP6L promotes tumor growth and metastasis of HCT116 cells in vivo
In agreement with in vitro analyses, HCT116 cells with overexpressed levels of ATP6L grew into larger tumor masses, as shown in Figure 5A ,B (Day 25:310 ± 81 mm 3 vs 186 ± 45 mm 3 , t = 2.702, P = 0.027; Day 30:400 ± 49.4 mm 3 vs 220 ± 29.5 mm 3 , t = 3.138, P = 0.0138). Among the 10 mice injected with ATP6L-overexpressed HCT116 cells, 1 showed tumor invasion into the surrounding adipose tissue and another exhibited the formation of intravascular tumor thrombus, whereas no metastasis sites were detected in mice injected with control cells ( Figure 5C ). We further established lung metastasis mouse models by tail vein injection and found that ATP6L overexpressing HCT116 cells formed more lung metastatic nodules ( Figure 5D These results indicate the angiogenesis-promoting effect of ATP6L on CRC. In the in vitro MTT analysis the proliferation of ATP6Loverexpressing cells showed no significant differences from the control cells, whereas our result in the animal experiment showed that ATP6L-overexpressing cells produced larger tumor masses than control cells. It has been reported that an acidic extracellular 
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